PFE — Pfizer Inc

Ownership history in Achmea Investment Management B.V.  ·  30 quarters on record

This page tracks every 13F SEC filing in which Achmea Investment Management B.V. reported a position in Pfizer Inc (PFE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.89% (2018 Q4)
Avg. % of fund
0.83%
First filed
2017 Q1
Last filed
2025 Q3
Quarters held
30
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 526,616 +201,826 +62.1% 0.17% $13.4M $24.63
2025 Q2 ADDED 324,790 +12,888 +4.1% 0.10% $7.9M $23.03
2025 Q1 ADDED 311,902 +205,886 +194.2% 0.12% $7.9M $23.63
2024 Q4 REDUCED 106,016 -92,571 -46.6% 0.05% $2.8M $24.33
26 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    PFE price (monthly, adj. close)

Other funds also holding PFE

As of 2025 Q4 — sorted by position size

Talaria Asset Management Pty Ltd 8.49% Patrick Mauro Investment Advisor, INC. 3Y 6.24% SECTOR GAMMA AS 3Y 7Y 4.88% WILSEY ASSET MANAGEMENT INC 3Y 7Y 4.62% CONTINENTAL ADVISORS LLC 3Y 7Y 4.22% Round Hill Asset Management 3Y 7Y 3.88% Corecam Pte. Ltd. 3.82% America First Investment Advisors, LLC 3Y 7Y 3.79% Drystone LLC 3Y 3.72% Socorro Asset Management LP 3Y 3.68%
← Back to Achmea Investment Management B.V. Holdings